Cumberland Pharmaceuticals Inc. (CPIX) Operating margin 2016–2025
Cumberland Pharmaceuticals Inc. (CPIX) operating margin by fiscal year — reported operating income divided by reported revenue.
-6.3%FY2025 · since FY2016: -4.4% → -6.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6.3% | +10.7 pp |
| FY2024 | -17.0% | +7.2 pp |
| FY2023 | -24.2% | -10.6 pp |
| FY2022 | -13.6% | +8.3 pp |
| FY2021 | -21.9% | -4.1 pp |
| FY2020 | -17.8% | +10.9 pp |
| FY2019 | -28.7% | +10.1 pp |
| FY2018 | -38.8% | -28.7 pp |
| FY2017 | -10.1% | -5.7 pp |
| FY2016 | -4.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CPIX financial trends
CPIX RevenueCPIX Net incomeCPIX Net marginCPIX Gross profitCPIX Gross marginCPIX Operating incomeCPIX Operating cash flowCPIX Free cash flowCPIX Capital expendituresCPIX Return on equityCPIX Stock buybacksCPIX Dividends paidCPIX Total assetsCPIX Total liabilitiesCPIX Shareholders’ equityCPIX overview →